Source: Cellular Oncology. Unidades: ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, ANTINEOPLÁSICOS, CITOESQUELETO, EXPRESSÃO GÊNICA, GENÔMICA, TRANSDUÇÃO DE SINAL CELULAR
ABNT
SILVA, Jean Carlos Lipreri da et al. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia. Cellular Oncology, v. 44, n. 5, p. 1105-1117, 2021Tradução . . Disponível em: https://doi.org/10.1007/s13402-021-00621-0. Acesso em: 30 jun. 2024.APA
Silva, J. C. L. da, Silva, J. L. C., Lima, K., Vicari, H. P., Lazarini, M., Lotufo, L. V. C., et al. (2021). Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia. Cellular Oncology, 44( 5), 1105-1117. doi:10.1007/s13402-021-00621-0NLM
Silva JCL da, Silva JLC, Lima K, Vicari HP, Lazarini M, Lotufo LVC, Traina F, Machado Neto JA. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia [Internet]. Cellular Oncology. 2021 ; 44( 5): 1105-1117.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1007/s13402-021-00621-0Vancouver
Silva JCL da, Silva JLC, Lima K, Vicari HP, Lazarini M, Lotufo LVC, Traina F, Machado Neto JA. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia [Internet]. Cellular Oncology. 2021 ; 44( 5): 1105-1117.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1007/s13402-021-00621-0